News Summary
The 2025 EndoRISE Fall Forum, held on December 8 at The Jackson Laboratory in Farmington, CT, gathered experts to address challenges in endometriosis diagnosis and treatment. Organized by EndoRISE, this event highlighted the need for less invasive diagnostic tools and improved management strategies. The forum also showcased pioneering research and technological advancements aimed at enhancing women’s health, fostering collaboration among stakeholders, and driving progress in understanding this complex disease, which affects millions globally.
Farmington, CT – Leaders from across the scientific, medical, policy, and patient advocacy communities recently convened at The Jackson Laboratory (JAX) in Farmington for the 2025 EndoRISE Fall Forum, a pivotal event dedicated to accelerating innovation in endometriosis research and patient care. The forum, held on December 8, 2025, brought together a diverse group of experts and stakeholders, both in-person and through a global virtual broadcast, to address critical challenges in diagnosing and treating endometriosis and to foster collaborative solutions for improving women’s health nationwide and worldwide.
Organized by EndoRISE, a state-supported initiative spearheaded by leaders from JAX and the University of Connecticut School of Medicine, the forum served as a dynamic platform for dialogue on the significant hurdles and emerging breakthroughs shaping the future of endometriosis care. Participants included researchers, clinicians, policymakers, patient advocates, and industry representatives, all united by a shared commitment to deepening understanding and raising awareness of this debilitating disease. The initiative, established in 2023, represents a first-of-its-kind statewide program designed to tackle endometriosis from multiple angles.
Addressing Diagnostic and Treatment Complexities
A central focus of the forum was the persistent complexity of diagnosing and treating endometriosis, as well as the historical difficulties in bringing attention to conditions that primarily affect women. Endometriosis, a condition where tissue similar to the lining inside the uterus grows outside it, affects an estimated 200 million individuals worldwide. In the United States alone, approximately 6.5 million individuals are impacted, with one in ten people in Connecticut suffering from the disease. Despite its widespread prevalence, endometriosis causes and biology remain poorly understood, often leading to reliance on invasive diagnostics and a lack of definitive treatments or cures. It is also a leading cause of hysterectomies among individuals of reproductive age.
Discussions highlighted the urgent need for less invasive diagnostic tools and more effective management strategies. Current diagnostic methods frequently involve significant delays and misdiagnosis due to the condition’s complex and varied symptoms. Lifelong management often requires therapies such as hormone treatment, surgical interventions, and lifestyle adjustments, underscoring the critical need for deeper scientific insight and improved options for patients.
Pioneering Research and Technological Advancements
The forum showcased cutting-edge advancements and innovation in several areas crucial to endometriosis care. Scientific presentations covered novel diagnostic approaches, including the potential use of menstrual blood for detection and investigations into genetic associations. Researchers also explored intriguing connections, such as the relationship between Lyme disease and endometriosis. Surgical and clinical perspectives on advancing care were also shared, alongside a focus on medical therapies and scientific discovery.
Technological innovations emerged as a key theme in enhancing diagnostic capabilities. These include the refinement of imaging techniques such as high-resolution ultrasound and magnetic resonance imaging (MRI), which offer improved visualization of endometrial lesions and can aid in pain management strategies. Advanced techniques like PET scans are also being explored for more precise identification of lesions. Furthermore, the application of artificial intelligence (AI) and machine learning is proving transformative, enhancing the interpretation of imaging results and aiding in clinical decision-making by identifying patterns that traditional analysis might miss. The forum also touched upon the promise of nanotechnology in developing accurate and non-invasive tools for biomarker detection, potentially revolutionizing early diagnosis without the need for surgical intervention. The importance of collaborative research in driving these less invasive diagnostic tools was strongly emphasized.
Advocacy and Community-Driven Progress
Patient advocacy and community engagement were underscored as vital components in driving progress for endometriosis care. Panel discussions featured representatives from prominent patient advocacy organizations, who shared their perspectives on ongoing challenges, advancements, and future directions. A “Fireside Chat” brought together leaders from major advocacy groups, reinforcing the power of community in turning personal struggles into scientific breakthroughs.
State Representative Jillian Gilchrest highlighted the significant suffering experienced by women in Connecticut due to endometriosis, noting that many have endured the condition in silence for too long. She emphasized that events like the EndoRISE Fall Forum bring much-needed attention to the disease and the lived experiences of those affected. The partnerships forged at the forum are expected to form a strong foundation for progress, not only at the state level but also nationally and beyond. The collective mission of increasing disease recognition, providing advocacy, and supporting education efforts was a resounding message throughout the event.
Looking Ahead
The 2025 EndoRISE Fall Forum reinforced the steadfast commitment of JAX and the University of Connecticut to advancing women’s health and fostering robust collaboration among researchers, clinicians, and the patient community. By uniting diverse stakeholders, the forum aims to accelerate the development of better treatments and outcomes for the millions impacted by endometriosis worldwide. The ongoing investigation and collaborative efforts championed by initiatives like EndoRISE are considered essential to moving beyond invasive diagnostics and establishing definitive treatments or a cure for this complex disease.
The forum’s emphasis on scientific ingenuity and interdisciplinary teamwork highlights a proactive approach to addressing a condition that has historically faced diagnostic delays and limited treatment options. The collective efforts initiated at the EndoRISE Fall Forum are expected to pave the way for a future where endometriosis is better understood, more effectively diagnosed, and comprehensively managed, ultimately improving the quality of life for affected individuals.
Frequently Asked Questions (FAQ)
- What was the 2025 EndoRISE Fall Forum?
- The 2025 EndoRISE Fall Forum was a pivotal event that united leaders from across scientific, medical, policy, and patient advocacy communities to advance innovation in endometriosis research and care.
- When and where did the forum take place?
- The forum took place on December 8, 2025, at The Jackson Laboratory (JAX) in Farmington, Connecticut, and was also streamed virtually to participants worldwide.
- Who organized the EndoRISE Fall Forum?
- The forum was organized by EndoRISE, a state-supported initiative led by The Jackson Laboratory (JAX) and the University of Connecticut School of Medicine. The initiative was established in 2023 through a collaboration between JAX, UConn Health, and Connecticut’s Endometriosis Working Group.
- Who attended the forum?
- Attendees included researchers, clinicians, policymakers, patient advocates, and industry partners.
- What were the key topics discussed at the forum?
- Key topics included the complexity of diagnosing and treating endometriosis, barriers to care, and the historic challenges of drawing attention to conditions primarily affecting women. Discussions also covered advancements in surgical approaches, medical therapies, scientific discovery, and novel diagnostic methods.
- How many people are affected by endometriosis?
- Endometriosis affects an estimated 200 million individuals worldwide, including about 6.5 million in the United States and 1 in 10 people in Connecticut.
Key Features of the EndoRISE Fall Forum
| Feature | Description | Geographic Scope |
|---|---|---|
| Event Name | 2025 EndoRISE Fall Forum | State-level (Connecticut-based initiative), Global (virtual attendance) |
| Date | December 8, 2025 | N/A |
| Location | The Jackson Laboratory (JAX), Farmington, Connecticut | State-level |
| Organizers | EndoRISE (JAX, University of Connecticut School of Medicine, Connecticut’s Endometriosis Working Group) | State-level initiative with nationwide and worldwide impact goals |
| Attendees | Researchers, Clinicians, Policymakers, Patient Advocates, Industry Partners | N/A |
| Primary Goal | Advance innovation in endometriosis research and care | Nationwide and Worldwide impact goals |
| Key Discussion Areas | Diagnostic and treatment complexities, barriers to care, novel diagnostic approaches, scientific discoveries, patient advocacy | N/A |
| Endometriosis Prevalence | Estimated 200 million individuals worldwide; 6.5 million in the United States; 1 in 10 in Connecticut | Worldwide, Nationwide, State-level |